Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common (2009 - 2018)
Teva Pharmaceutical Industries' (TEVA) quarterly Dividends Paid - Common came in at $12.0 million in Q1 2018, down 96.53% YoY from $346.0 million in Q1 2017, and down 86.21% on a QoQ basis from $87.0 million in Q4 2017.
Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common (2009 - 2018) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 10 years of Dividends Paid - Common data on file, last reported at $12.0 million in Q1 2018.
- Quarterly Dividends Paid - Common fell 96.53% year-over-year to $12.0 million in Q1 2018, while the trailing twelve-month figure through Dec 2018 was $12.0 million (down 98.67% YoY) and the FY2018 annual result came in at $12.0 million, down 98.67% from the prior year.
- Dividends Paid - Common fell to $12.0 million in Q1 2018, from $87.0 million in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $346.0 million in Q4 2016 to a low of $12.0 million in Q1 2018.
- A 5-year average of $266.3 million and a median of $291.0 million in 2014 frame the typical range for Dividends Paid - Common.
- Annual changes were most pronounced in 2016 — Dividends Paid - Common advanced 19.31% — and 2018, when it plunged 96.53%.
- Tracing TEVA's Dividends Paid - Common over 5 years: stood at $272.0 million in 2014, then increased by 6.62% to $290.0 million in 2015, then gained by 19.31% to $346.0 million in 2016, then slumped by 74.86% to $87.0 million in 2017, then tumbled by 86.21% to $12.0 million in 2018.
- The last three Dividends Paid - Common figures came in at $12.0 million (Q1 2018), $87.0 million (Q4 2017), and $123.0 million (Q3 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 223.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -941.91 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 139.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 12.00 Mn |
| Mar 31, 2018 | 12.00 Mn |
| Dec 31, 2017 | 87.00 Mn |
| Dec 31, 2017 | 87.00 Mn |
| Sep 30, 2017 | 123.00 Mn |
| Sep 30, 2017 | 123.00 Mn |
| Jun 30, 2017 | 345.00 Mn |
| Jun 30, 2017 | 345.00 Mn |
| Mar 31, 2017 | 346.00 Mn |
| Mar 31, 2017 | 346.00 Mn |
| Dec 31, 2016 | 346.00 Mn |
| Dec 31, 2016 | 346.00 Mn |
| Sep 30, 2016 | 340.00 Mn |
| Sep 30, 2016 | 340.00 Mn |
| Jun 30, 2016 | 310.00 Mn |
| Jun 30, 2016 | 310.00 Mn |
| Mar 31, 2016 | 307.00 Mn |
| Mar 31, 2016 | 307.00 Mn |
| Dec 31, 2015 | 290.00 Mn |
| Dec 31, 2015 | 290.00 Mn |